{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"98.800","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"27,553,260","primaryexch":"香港交易所","ric":"6821.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":2.69,"inline_upper_strike_price":"","sedol":"BNYGMN1","am":"61.23","iv":"","ew_strike":"","as":"92.800","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"92.750","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"39.950","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"Hao Hong","underlying_ric":"002821.SZ","hi52":"116.600","issuer_name":"凱萊英醫藥集團(天津)股份有限公司 - H股","h_share_flag":true,"ew_sub_per_from":"","div_yield":"1.30","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"92.300","mkt_cap":"2.55","f_aum_hkd":null,"ew_sub_per_to":"","ls":"92.800","nav_date":"","csic_classification":"醫藥衛生","floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-7.500","aum":"","issued_shares_class_B":null,"vo":"643.60","secondary_listing_flag":false,"listing_date":"2021年12月10日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"凱萊英醫藥集團(天津)股份有限公司 - H股","nm_s":"凱萊英","sym":"6821","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"凱萊英醫藥集團（天津）股份有限公司是一家主要從事提供醫藥外包一站式綜合服務的中國公司。該公司的業務包括小分子藥物定製研發生產（CDMO）、化學大分子CDMO、臨床研究服務、製劑CDMO、生物大分子CDMO、技術輸出和合成生物技術。該公司的產品類別涵蓋多肽、寡核苷酸、單克隆抗體、抗體偶聯藥物和信使RNA等。該公司主要在國內外市場開展其業務。","op":"98.800","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"藥品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國<br/>天津市<br/>經濟技術開發區<br/>洞庭三街6號","pc":"-7.48","days_to_expiry":null,"underlying_code":null,"pe":"32.62","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"100.300","isin":"CNE100004Z06","moneyness":""}},"qid":"1759074196520"}
